Suppressive effect of anticardiolipin antibody on the proliferation of human umbilical vein endothelial cells

Fertility and Sterility

Volumn 71, Issue 6, 1999, Pages 1103-1107

  Arakawa, Masato ^a   Takakuwa, Koichi ^a   Honda, Keisuke ^a   Tamura, Masaki ^a   Kurabayashi, Takumi ^a   Tanaka, Kenichi ^b  

^a NIIGATA UNIVERSITY   (Japan)

^b NONE

Author keywords

Anticardiolipin antibody; HUVEC; Infertility; Suppressive effect

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; PROTEIN;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT ABORTION;

ABORTION, HABITUAL; ADULT; ANTIBODIES, ANTICARDIOLIPIN; CELL DIVISION; CELLS, CULTURED; DNA; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLASTS; HUMANS; PREGNANCY; RETROSPECTIVE STUDIES; UMBILICAL VEINS;

EID: 0033151686     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(99)00117-X     Document Type: Article

References (23)

1. Lockshin M.D., Druzin M.L., Goei S., Qamar T., Magid M.S., Jovanovic L., et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med. 313:1985;152-156.
2. Branch D.W., Scott J.R., Kochenour N.K., Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med. 313:1985;1322-1326.
3. Yasuda M., Takakuwa K., Tokunaga A., Tanaka K. Prospective study of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol. 86:1995;555-559.
4. Hughes G.R.V., Harris E.N., Gharavi A.E. The anticardiolipin syndrome. J Rheumatol. 13:1986;486-491.
5. Gleicher N., El-Roeiy A. Reproductive autoimmune failure syndrome. Am J Obstet Gynecol. 159:1988;223-227.
6. De Wolf F., Carreras L.O., Moerman P., Vermylen J., Van Assche A., Renauer M. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and lupus anticoagulant. Am J Obstet Gynecol. 142:1982;829-834.
7. Carreras L.O., Defreyn G., Machin S.J., Vermylen J., Deman R., Spitz B., et al. Arterial thrombosis, intrauterine death and lupus anticoagulant detection of immunoglobulin interfering with prostacyclin formation . Lancet. 1:1981;224-226.
8. Loizou S., McCrea J.D., Rudge A.C., Reynolds R., Boyle C.C., Harris E.N. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA) standardization and quantitation of results . Clin Exp Immunol. 62:1985;738-745.
9. Harris E.N., Gharavi A.E., Patel S.P., Hughes G.R.V. Evaluation of anticardiolipin antibody test report of an international workshop held 4 April 1986 . Clin Exp Immunol. 62:1987;738-745.
10. Jaffe E.A., Hoyer L.W., Nachman R.L. Synthesis of antihemophilic factor antigen by cultured human cells. J Clin Invest. 52:1973;2757-2764.
11. Grimes D.A., LeBolt S.A., Grimes K.R., Wingo P.A. Systemic lupus erythematosus and reproductive function a case-control study . Am J Obstet Gynecol. 153:1985;179-186.
12. Branch D.W., Andres R., Digre K.B., Rote N.S., Scott J.R. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol. 73:1989;541-545.
13. Carreras L.O., Vermylen J.G. "Lupus" anticoagulant and thrombosis - possible role of inhibition of prostacyclin formation. Thromb Haemost. 48:1982;38-40.
14. Rustin M.H., Bull H.A., Machin S.J., Isenberg D.A., Snaith M.L., Dowd P.M. Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on cell prostacyclin release and procoagulant activity. J Invest Dermatol. 90:1988;744-748.
15. Dudley D.J., Mitchell M.D., Branch D.W. Pathophysiology of antiphospholipid antibodies absence of prostaglandin-mediated effects on cultured endothelium . Am J Obstet Gynecol. 162:1990;953-958.
16. Dueymes M., Levy Y., Ziporen L., Jamin C., Piette J.C., Shoenfeld Y., et al. Do some antiphospholipid antibodies target cells? Ann Med Interne (Paris). 147:(Suppl 1):1996;22-23.
17. Gleicher N., Harlow L., Zilberstein M. Regulatory effect of antiphospholipid antibodies on signal transduction a possible model for autoantibody-induced reproductive failure . Am J Obstet Gynecol. 167:1992;637-642.
18. Rote N.S., Vogt E., DeVere G., Obringer A.R., Ng A.K. The role of placental trophoblast in the pathophysiology of the antiphospholipid antibody syndrome. Am J Reprod Immunol. 39:1998;125-136.
19. Matsuura E., Igarashi Y., Fujimoto M., Ichikawa K., Suzuki T., Sumida T., et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol. 148:1992;3885-3891.
20. Aoki K., Dudkiewicz A.B., Matsuura E., Novotny M., Kaberlein G., Gleicher N. Clinical significance of beta 2-glycoprotein I-dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome correlation with conventional antiphospholipid antibody detection systems . Am J Obstet Gynecol. 172:1995;926-931.
21. Wurm H. Beta 2-glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles. Int J Biochem. 16:1984;511-515.
22. Nimpf J., Wurm H., Kostner G.M. Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation. Atherosclerosis. 63:1987;109-114.
23. Shi W., Chong B.H., Hogg P.J., Chesterman C.N. Anticardiolipin antibodies block the inhibition by beta 2-glycoprotein I of the factor Xa generating activity of platelets. Thromb Haemost. 70:1993;342-345.